ClinicalTrials.gg
Sign In

Drug

TVAX-008 clinical trials

Also written TVAX-008.

studies test it
4
open now
1
in phase 3
0
first study started
2023

Keep track of what changes. Save the TVAX-008 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

TVAX-008
4

Studies by the year they started

4 studies that test it; most in 2023 (1)

Studies that test TVAX-008, by start year
YearStudies
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
1
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Hepatitis B, Chronic
3

Who runs them

Industry 4 · Other 0

Grand Theravac Life Sciences (Nanjing) Co., Ltd. (3) · Ausper Biopharma Co., Ltd. (1)

Studies

Open first, then newest update. How each study uses TVAX-008 is read from its arms, and is right about nine times in ten.

Testing it · 4